Pharma-Bio Serv Announces Special Dividend
03/01/2023 - 09:15 AM
DORADO, PUERTO RICO / ACCESSWIRE / March 1, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders. The Special Dividend will be payable on or about April 14, 2023 to shareholders of record at the close of business on March 29, 2023.
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv services the Puerto Rico, United States, Europe and Latin America markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.
Forward-Looking Statements
This news release contains "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are inherently subject to significant business risks, economic uncertainties, and competitive uncertainties, and other factors, which could cause Pharma-Bio Serv's actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Pharma-Bio Serv's actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of Pharma-Bio Serv's Annual Report on Form 10-K for the year ended October 31, 2022, and in its other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov . Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.
Company Contact:
Pedro J. Lasanta
SOURCE: Pharma-Bio Serv, Inc.
View source version on accesswire.com:
https://www.accesswire.com/741422/Pharma-Bio-Serv-Announces-Special-Dividend
PBSV Rankings
N/A Ranked by Stock Gains
PBSV Stock Data
Industry
Testing Laboratories
Sector
Professional, Scientific, and Technical Services
Tags
Miscellaneous Commercial Services, Commercial Services, Professional, Scientific, and Technical Services, Testing Laboratories
About PBSV
pharma-bio serv is the life sciences industry leader in regulatory compliance, validation, and other regulated industry support services. founded in february 1993, pharma-bio serv offers technical services, product and process transfers, commissioning, process engineering, and technology transfer, to pharmaceutical, medical devices, consumer, chemical and biotechnology industries in puerto rico, united states, brazil and europe. our diverse team offers an integrated service structure designed to provide complete solutions for our client needs. following this holistic approach, we diversified our services with new divisions to support our clients: a laboratory testing facility in puerto rico and spain, scienzalabs, offering microbiological and analytical testing services; metrologix, provides a full range of calibration program management solutions, including calibration standard management, annual calibration workload balancing, and scheduling and data entry; integratek, providing it/s
